About

Contact Us

Aldeyra Therapeutics
131 Hartwell Avenue, Suite 320
Lexington, MA 02421

Telephone: (781) 761-4904
Fax: (339) 674-6495

Aldeyra Therapeutics is a biotechnology company devoted to developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. Aldeyra’s lead product candidates are first-in-class treatments in development for dry eye disease, allergic conjunctivitis, proliferative vitreoretinopathy, and Sjögren-Larsson Syndrome. The company is also developing other product candidates for retinal and systemic inflammatory diseases. None of Aldeyra’s product candidates have been approved for sale in the U.S. or elsewhere.

We are a publicly traded company on The Nasdaq Capital Market, ticker ALDX.

Have a question, comment or request?

Use the form below to send us a note and we’ll get back to you.